Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 2.3B | 3.0B | 3.4B |
Cost of revenue | 3.1B | 2.0B | 2.5B | 3.0B |
Gross profit | 343.8M | 288.1M | 471.8M | 434.6M |
Operating expense | ||||
Research & development | 97.7M | 47.1M | 113.2M | 113.5M |
Selling general and admin | 111.0M | -272.6M | 309.1M | -18.6M |
Other operating expenses | 12.3M | 33.6M | -3.3M | 20.3M |
Operating income | 129.5M | 207.6M | 216.5M | 172.4M |
Non operating interest income | ||||
Income | 12.0M | 9.0M | 24.9M | 67.1M |
Expense | 15.0M | 9.4M | 17.4M | 27.9M |
Other income expense | — | — | — | — |
Pretax income | 155.4M | 124.5M | 228.0M | 235.2M |
Tax provision | 17.9M | 11.0M | 26.7M | 30.6M |
Net income | 137.5M | 113.6M | 201.3M | 204.7M |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 696.0M | — | — | — |
Diluted average shares | 696.0M | — | — | — |
EBITDA | 174.2M | 230.0M | 250.9M | 263.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | -37.2M | -39.3M | -52.2M | -57.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |